Elderly patients' adherence to statin therapy

JAMA

Volumn 288, Issue 4, 2002, Pages 495-497

  Applegate, William B ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CONGESTIVE HEART FAILURE; DIABETES MELLITUS; EDITORIAL; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0037167060     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.4.495     Document Type: Editorial

References (16)

1. Long-term persistence in use of statin therapy in elderly patients
2. Adherence with statin therapy in elderly patients with and without acute coronary syndromes
3. Postdischarge lipid management of coronary artery disease patients according to the new National Cholesterol Education Program guidelines
4. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin Survival Study
5. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial
6. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range: Results of the Cholesterol and Recurrent Events Trial (CARE)
7. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
8. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial
9. Withdrawal of statins increases event rates in patients with acute coronary syndromes
10. The effects of initial drug choice and comorbidity on antihypertensive medication compliance
11. Noncompliance with congestive heart failure therapy in the elderly
12. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
13. Clinical treatment of dyslipidemia: Practice patterns and missed opportunities
14. Persistence of use of lipid-lowering medications: A cross-national study
15. Cholesterol lowering in the elderly: Results of the Cholesterol Reduction in Seniors Program (CRISP) pilot study
16. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial